Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

A novel CCAAT/enhancer binding protein α germline variant in a case of acute myeloid leukemia.

Gutman JA, Hoffner B.

Leuk Lymphoma. 2012 May;53(5):1006-7. doi: 10.3109/10428194.2011.638718. Epub 2012 Jan 3. No abstract available.

PMID:
22066712
[PubMed - indexed for MEDLINE]
2.

Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML.

Stelljes M, Corbacioglu A, Schlenk RF, Döhner K, Frühwald MC, Rossig C, Ehlert K, Silling G, Müller-Tidow C, Juergens H, Döhner H, Berdel WE, Kienast J, Koschmieder S.

Leukemia. 2011 Jul;25(7):1209-10. doi: 10.1038/leu.2011.64. Epub 2011 Apr 1. No abstract available.

PMID:
21455213
[PubMed - indexed for MEDLINE]
3.

A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation.

Nanri T, Uike N, Kawakita T, Iwanaga E, Mitsuya H, Asou N.

Genes Chromosomes Cancer. 2010 Mar;49(3):237-41. doi: 10.1002/gcc.20734.

PMID:
19953636
[PubMed - indexed for MEDLINE]
4.

[Detection of CCAAT/enhancer binding protein alpha gene mutations in acute myeloid leukemia].

Zhao JM, Wang HW, Xu ZF, Zhu L, Bai B, Ge XY.

Zhonghua Xue Ye Xue Za Zhi. 2005 May;26(5):299-302. Chinese.

PMID:
15949295
[PubMed - indexed for MEDLINE]
5.

Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation.

Renneville A, Mialou V, Philippe N, Kagialis-Girard S, Biggio V, Zabot MT, Thomas X, Bertrand Y, Preudhomme C.

Leukemia. 2009 Apr;23(4):804-6. doi: 10.1038/leu.2008.294. Epub 2008 Oct 23. No abstract available.

PMID:
18946494
[PubMed - indexed for MEDLINE]
6.

Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia.

Sellick GS, Spendlove HE, Catovsky D, Pritchard-Jones K, Houlston RS.

Leukemia. 2005 Jul;19(7):1276-8. No abstract available.

PMID:
15902292
[PubMed - indexed for MEDLINE]
7.

[Comprehensive analysis of gene abnormalities in acute myeloid leukemia according to the WHO classification].

Ishikawa Y.

Rinsho Ketsueki. 2009 Aug;50(8):597-603. Japanese. No abstract available.

PMID:
19915373
[PubMed - indexed for MEDLINE]
8.

Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.

Pabst T, Eyholzer M, Haefliger S, Schardt J, Mueller BU.

J Clin Oncol. 2008 Nov 1;26(31):5088-93. doi: 10.1200/JCO.2008.16.5563. Epub 2008 Sep 2.

PMID:
18768433
[PubMed - indexed for MEDLINE]
Free Article
9.

Disruption of C/EBPalpha function in acute myeloid leukemia.

Fröhling S, Döhner H.

N Engl J Med. 2004 Dec 2;351(23):2370-2. No abstract available.

PMID:
15575052
[PubMed - indexed for MEDLINE]
10.

Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.

Asou H, Gombart AF, Takeuchi S, Tanaka H, Tanioka M, Matsui H, Kimura A, Inaba T, Koeffler HP.

Genes Chromosomes Cancer. 2003 Feb;36(2):167-74.

PMID:
12508245
[PubMed - indexed for MEDLINE]
11.

[Analysis of CEBPA mutation in acute myeloid leukemia].

Zhang Y, Zhang SJ, Qiu HX, Qiao C, Sun HM, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):859-62. Chinese.

PMID:
20723288
[PubMed - indexed for MEDLINE]
12.

Mutation of CEBPA in familial acute myeloid leukemia.

Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J.

N Engl J Med. 2004 Dec 2;351(23):2403-7.

PMID:
15575056
[PubMed - indexed for MEDLINE]
Free Article
13.

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.

Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG.

Nat Genet. 2001 Mar;27(3):263-70.

PMID:
11242107
[PubMed - indexed for MEDLINE]
14.

Hereditary thrombocytopenia and acute myeloid leukemia: a common link due to a germline mutation in the AML1 gene.

Appelmann I, Linden T, Rudat A, Mueller-Tidow C, Berdel WE, Mesters RM.

Ann Hematol. 2009 Oct;88(10):1037-8. doi: 10.1007/s00277-009-0722-x. Epub 2009 Apr 1. No abstract available.

PMID:
19337732
[PubMed - indexed for MEDLINE]
15.

Differentiation or leukemia: is C/EBPalpha the answer?

Hiebert S.

Nat Med. 2001 Apr;7(4):407-8. No abstract available.

PMID:
11283659
[PubMed - indexed for MEDLINE]
16.

[Analysis of leukemogenesis induced by C/EBPα mutations].

Kato N.

Rinsho Ketsueki. 2011 Jun;52(6):320-8. Review. No abstract available.

PMID:
21737983
[PubMed - indexed for MEDLINE]
17.

Familial myelodysplasia and acute myeloid leukaemia--a review.

Owen C, Barnett M, Fitzgibbon J.

Br J Haematol. 2008 Jan;140(2):123-32. doi: 10.1111/j.1365-2141.2007.06909.x. Review.

PMID:
18173751
[PubMed - indexed for MEDLINE]
18.

Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein α with 13 years difference at onset.

Debeljak M, Kitanovski L, Pajič T, Jazbec J.

Haematologica. 2013 Jul;98(7):e73-4. doi: 10.3324/haematol.2012.082578. Epub 2013 May 28. No abstract available.

PMID:
23716546
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Diagnosis and prognosis in acute myeloid leukemia--the art of distinction.

Löwenberg B.

N Engl J Med. 2008 May 1;358(18):1960-2. doi: 10.1056/NEJMe0802379. No abstract available.

PMID:
18450608
[PubMed - indexed for MEDLINE]
20.

Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.

Green CL, Koo KK, Hills RK, Burnett AK, Linch DC, Gale RE.

J Clin Oncol. 2010 Jun 1;28(16):2739-47. doi: 10.1200/JCO.2009.26.2501. Epub 2010 May 3.

PMID:
20439648
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk